Resultados da pesquisa - Sven D. Koch
- A mostrar 1 - 11 resultados de 11
-
1
Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Por Othmar Dill, Femia Kievits, Sven D. Koch, P Iványi, G J Hämmerling
Publicado em 1988Artigo -
2
-
3
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial Por Fatma Doener, Henoch S. Hong, Ingo Meyer, Keyvan Tadjalli-Mehr, Angelika Daehling, Regina Heidenreich, Sven D. Koch, Mariola Fotin‐Mleczek, Ulrike Gnad-Vogt
Publicado em 2019Artigo -
4
-
5
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas Por Sebastian Attig, Jörg Hennenlotter, Graham Pawelec, Gerd Klein, Sven D. Koch, Hanspeter Pircher, Susan Feyerabend, Dorothee Wernet, Arnulf Stenzl, Hans‐Georg Rammensee, Cécile Gouttefangeas
Publicado em 2009Artigo -
6
Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses Por Geertrude H. Struijk, Robert C. Minnee, Sven D. Koch, Aeilko H. Zwinderman, K.A.M.I. van Donselaar–van der Pant, Mirza M. Idu, Ineke J. M. ten Berge, Fréderike J. Bemelman
Publicado em 2010Artigo -
7
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-... Por Martin Sebastian, Alexandros Papachristofilou, Christian Weiß, Martin Früh, Richard Cathomas, Wolfgang Hilbe, Thomas Wehler, Gerd Rippin, Sven D. Koch, Birgit Scheel, Mariola Fotin‐Mleczek, Regina Heidenreich, Karl‐Josef Kallen, Ulrike Gnad-Vogt, Alfred Zippelius
Publicado em 2014Artigo -
8
Immunosenescence and Cytomegalovirus: where do we stand after a decade? Por Graham Pawelec, Arne N. Akbar, Peter C. L. Beverley, Calogero Caruso, Evelyna Derhovanessian, Tamàs Fülöp, Paul Griffiths, Beatrix Grubeck‐Loebenstein, Klaus Hamprecht, Gerhard Jahn, Florian Kern, Sven D. Koch, Anis Larbi, Andrea B. Maier, Derek C. Macallan, Paul Moss, Sandrine I. Samson, Jan Strindhall, Emanuelle Trannoy, Mark R. Wills
Publicado em 2010Editorial -
9
Deep Sequencing of Antiviral T-Cell Responses to HCMV and EBV in Humans Reveals a Stable Repertoire That Is Maintained for Many Years Por Paul L. Klarenbeek, Ester B. M. Remmerswaal, Ineke J. M. ten Berge, Marieke E. Doorenspleet, Barbera D. C. van Schaik, R. E. Esveldt, Sven D. Koch, Anja ten Brinke, Antoine H. C. van Kampen, F. J. Bemelman, Paul P. Tak, Frank Baas, Niek de Vries, René A. W. van Lier
Publicado em 2012Artigo -
10
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays Por Cedrik M. Britten, Cécile Gouttefangeas, Marij J.P. Welters, Graham Pawelec, Sven D. Koch, Christian H. Ottensmeier, Ann Mander, Steffen Walter, Annette Paschen, Jan Müller‐Berghaus, I. Haas, Andréas Mackensen, Tania Køllgaard, Per thor Straten, Michael Schmitt, Krzysztof Giannopoulos, Reinhard Maier, Hendrik Veelken, Cristina Bertinetti, Abdo Konur, Christian G. Huber, Stefan Stevanović, Thomas Wölfel, Sjoerd H. van der Burg
Publicado em 2007Carta -
11
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with s... Por Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiß, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl‐Josef Kallen, Mariola Fotin‐Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt, Alfred Zippelius
Publicado em 2019Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Immunology
Immune system
Medicine
Biology
Virology
CD8
In vitro
Internal medicine
T cell
Adverse effect
Antigen
Cytotoxic T cell
Virus
Adjuvant
Biochemistry
Cancer
Cell biology
Cytomegalovirus
Effector
Gene
Genetics
Herpesviridae
Human cytomegalovirus
Immunogenicity
Immunotherapy
Lung cancer
Oncology
Physics
Progressive disease
Response Evaluation Criteria in Solid Tumors